Monoclonal antibodies selective for prostate cancer
US4970299A · kind A · utility
33Cited by
10References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 1986 |
| Grant date | Nov 13, 1990 |
| Priority date | — |
| Expiry date | Jul 3, 2006 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/861
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Four monoclonal antibodies are found which selectively identify prostate cancer. These monoclonals are therefore useful in diagnosis, differential diagnosis and treatment of prostate cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.